Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.03
31% from low
Borrow rate
10.50%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $122.7K | $668.6K | $2.3M | $1.7M | $4.6M | $6.7M | $2.2M | $0 |
| Cost of revenue | $44.5K | $405.5K | $598.6K | $278.1K | $1.6M | $4.1M | $1.8M | $742.3K |
| Gross profit | $78.3K | $263.1K | $1.7M | $1.4M | $3.0M | $2.6M | $358.7K | −$742.3K |
| Gross margin | 63.8% | 39.3% | 74.0% | 83.7% | 65.0% | 39.1% | 16.6% | — |
| R&D | $37.0K | $75.0K | $150.0K | $165.0K | $0 | $0 | $0 | $0 |
| Operating income | −$712.8K | −$3.4M | −$4.6M | −$7.5M | −$10.3M | −$14.2M | −$7.5M | −$4.8M |
| EBITDA | −$1.9M | −$3.8M | −$5.7M | −$7.2M | −$9.5M | −$12.6M | −$5.8M | −$7.7M |
| Net income | −$2.1M | −$4.1M | −$4.6M | −$8.9M | −$12.2M | −$14.9M | −$9.7M | −$10.2M |
| Net margin | -1743.2% | -615.1% | -199.2% | -519.3% | -264.3% | -223.2% | -451.7% | — |
| EPS (diluted) | -37.57 | -43.66 | -33.46 | -37.68 | -9.06 | -4.18 | -0.77 | -0.17 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds CANB.
No tracked institution reports a position in CANB as of their last filing.
| Execution date | Ratio |
|---|---|
| 2022-02-14 | 1-for-15reverse |
| 2020-03-06 | 1-for-300reverse |
No one on the platform has traded CANB yet.
| $1M |
| — |
| IWINFIrwin Naturals Inc. | $0.50 | +51.52% | $2M | — |
| KALOKallo Inc. | $0.00 | — | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.0× sales vs its 2.2× historical median P/S.
Fair value ≈ $1.23 · price $0.02 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
It's interesting... $SPY down ...... But my OTCs are up...is somebody digging out a position? Are risk outlooks adjusting? $BTCWF $STEK $CEOS $CANB
View on StockTwits ↗Nice inflows on OTC today!!!! $CAPC $BTCWF $CANB
View on StockTwits ↗$CANB Weed stocks are flying. MJ up 20%. The Trump trade🤑
View on StockTwits ↗$CANB Talked with the CEO of $CANB: - Fox Rothschild, their legal firm is going ahead by contacting the larger CBD Producers. - They will try to keep it amiable with regard to monetizing the patents. - He said the patents cover all aspects of CBD: beverages, tinctures, vape pen liquids, oils, gummies liquid-filled capsules and other non-flower products. - Also he reaffirmed the max value of over $750M. Z
View on StockTwits ↗Any day now, $CANB will release news on the progress of the monetization of $750M worth of Patents....... Z
View on StockTwits ↗Any day now, $CANB will release news on the progress of the monetization of $750M worth of Patents....... Z
View on StockTwits ↗Talked with the CEO of $CANB: - Fox Rothschild, their legal firm is going ahead by contacting the larger CBD Producers. - They will try to keep it amiable with regard to monetizing the patents. - He said the patents cover all aspects of CBD: beverages, tinctures, vape pen liquids, oils, gummies liquid-filled capsules and other non-flower products. - Also he reaffirmed the max value of over $750M. Z
View on StockTwits ↗Patents worth in excess of $750 Million!: $CANB The Can B patents were tested in an earlier litigation, survived, and now benefit from several favorable court rulings.
View on StockTwits ↗Why is $CANB a Great Buy? 1. They have 2 broad CBD/MJ patents that have been legally verified. 2. They just hired a major patent law firm (Fox Rothschild) to enforce/monetize them. 3. Every CBD and MJ manufacturer is going to have to give them licensing fees. 4. $750M+ is the estimated value of these fees. Read the details here: Fox Rothschild Legal Firm Hired - https://www.otcmarkets.com/stock/CANB/news/story?e&id=3205344
View on StockTwits ↗Talked with the CEO of $CANB: - Fox Rothschild, their legal firm is going ahead by contacting the larger CBD Producers. - They will try to keep it amiable with regard to monetizing the patents. - He said the patents cover all aspects of CBD: beverages, tinctures, vape pen liquids, oils, gummies liquid-filled capsules and other non-flower products. - Also he reaffirmed the max value of over $750M. Z
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.